SmallCap
CompaniesStatistics

주식회사 에이켐바이오

Venture Certified
Data Quality: 8/10

Basic Information


Unlisted

Company Name주식회사 에이켐바이오
Business Reg. No.1488101988
CEO조문제
Address제주특별자치도 제주시
Industry의학 및 약학 연구개발업
Industry Code70113
Main Products신약 연구개발
EstablishedContact
Phone064-756-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.134111-*******

Investment Metrics


Market Cap
-
Op. Margin
-217.44%
ROE
109.59%
Debt Ratio
-437.27%

Certification Status


Venture Certified

Cert. History
연구개발유형2022-09-28 ~ 2025-09-27202209280200222022-09-28
연구개발유형2025-09-28 ~ 2028-09-27202508270200172022-09-28

Financial Statements


3-Year Financial Data

Revenue CAGR +48.6%

Item202420232022
Revenue

0.4B

0.2B

0.2B

Operating Profit

-0.8B

-1.1B

-0.4B

Net Profit

-0.9B

-1.3B

-0.4B

Total Assets

2.8B

2.2B

2.8B

Total Liabilities

3.6B

3.4B

2.8B

Total Equity

-0.8B

-1.2B

0.0B

Risk Indicators


3 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
367610K

95.2%

vs. 3-Year Avg.: 188310K
Operating Profit
-799210K

4.5%

vs. 3-Year Avg.: -765110K
Op. Margin
-217.4%

44.0%

vs. 3-Year Avg.: -388.2%
Debt Ratio
-437.3%

110.2%

vs. 3-Year Avg.: 4267.5%
ROE
109.6%

117.5%

vs. 3-Year Avg.: -627.3%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
조문제대표이사대표

Employment Status


Regular EmployeesContact
CEO조문제

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "제주특별자치도 제주시",
  "ceo_name": "조문제",
  "certificate": [
    {
      "cert_number": "20220928020022",
      "changes": "",
      "disclosure_date": "2022-09-28",
      "first_cert_date": "2022-09-28",
      "no": "1",
      "type": "연구개발유형",
      "valid_period": "2022-09-28 ~ 2025-09-27"
    },
    {
      "cert_number": "20250827020017",
      "changes": "",
      "disclosure_date": "2025-08-27",
      "first_cert_date": "2022-09-28",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2025-09-28 ~ 2028-09-27"
    }
  ],
  "company_name": "주식회사 에이켐바이오",
  "corp_no": "134111-*******",
  "financials": {
    "2022": {
      "capital_stock": 182000000,
      "cost_of_sales": 0,
      "current_assets": 94358000,
      "current_liabilities": 77362000,
      "gross_profit": 16650000,
      "net_income": -42712000,
      "net_income_bs": -42712000,
      "non_current_assets": 186151000,
      "non_current_liabilities": 200000000,
      "non_operating_expenses": 7336000,
      "non_operating_income": 2967000,
      "operating_profit": -38343000,
      "revenue": 16650000,
      "sga_expenses": 54993000,
      "total_assets": 280509000,
      "total_equity": 3147000,
      "total_liabilities": 277362000
    },
    "2023": {
      "capital_stock": 182000000,
      "cost_of_sales": 0,
      "current_assets": 49970000,
      "current_liabilities": 129011000,
      "gross_profit": 21000000,
      "net_income": -125889000,
      "net_income_bs": -125889000,
      "non_current_assets": 169203000,
      "non_current_liabilities": 212904000,
      "non_operating_expenses": 12359000,
      "non_operating_income": 1143000,
      "operating_profit": -114673000,
      "revenue": 21000000,
      "sga_expenses": 135673000,
      "total_assets": 219173000,
      "total_equity": -122742000,
      "total_liabilities": 341915000
    },
    "2024": {
      "capital_stock": 313681000,
      "cost_of_sales": 0,
      "current_assets": 128899000,
      "current_liabilities": 137226000,
      "gross_profit": 36755000,
      "net_income": -90221000,
      "net_income_bs": -90221000,
      "non_current_assets": 148772000,
      "non_current_liabilities": 222774000,
      "non_operating_expenses": 11923000,
      "non_operating_income": 1622000,
      "operating_profit": -79920000,
      "revenue": 36755000,
      "sga_expenses": 116675000,
      "total_assets": 277671000,
      "total_equity": -82329000,
      "total_liabilities": 360000000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "신약 연구개발",
  "phone": "064-756-****",
  "years": [
    2024,
    2023,
    2022
  ]
}